The peptide synthesis market is projected to achieve significant growth, with its valuation expected to rise from USD 520.0 ...
The Peptide Builder accommodates a wide range of synthesis scales, from 50 µmol to 1.0 mmol. It can be used with any kind of polymeric resin, including PS, PEGylated resins, and the standard ...
BrisSynBio has two CEM Liberty Blue automated, microwave-assisted peptide synthesisers. These support Fmoc peptide synthesis of sequences from two to about fifty residues at a scale from one to about ...
After a roller coaster ride of successes and failures, new discovery technologies and advances in manufacturing promise a brighter future for peptides in human therapy. Some 40 years after Nobel ...
NORTH CHICAGO, Ill. - AbbVie (NYSE: NYSE:ABBV), a global biopharmaceutical company with a market capitalization of $299 billion and annual revenue exceeding $55 billion, has announced the completion ...
Nonribosomal peptides (NRPs) are a diverse class of natural ... This research not only clarifies the synthesis process but also opens avenues for re-engineering NRPSs to create new pharmaceutical ...
Meeting is thrilled to announce that Morten Meldal, Nobel Laureate and Professor of Chemistry at the University of Copenhagen ...
Peptides are short strands of amino acids that ... molecules that are important building blocks in organic synthesis ...
Creative Peptides, a leading research peptide innovator, announces enhancing its peptide library construction and screening services, which have been upgraded to accelerate drug development across ...
Cartalax peptide, a bioregulator derived from cartilage tissue, has garnered significant interest in scientific communities ...
AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Nimble Therapeutics. With the completion of the acquisition, Nimble is now a part of AbbVie.
Cell penetrating peptides expand pivotal roles in oncology, neurology, and immunotherapy, connecting specialized carriers with advanced molecular cargo, inspiring continuous R&D efforts and valuable ...